IN2012DN06631A - - Google Patents
Info
- Publication number
- IN2012DN06631A IN2012DN06631A IN6631DEN2012A IN2012DN06631A IN 2012DN06631 A IN2012DN06631 A IN 2012DN06631A IN 6631DEN2012 A IN6631DEN2012 A IN 6631DEN2012A IN 2012DN06631 A IN2012DN06631 A IN 2012DN06631A
- Authority
- IN
- India
- Prior art keywords
- yloxy
- methyl
- isoxazol
- pyran
- piperidin
- Prior art date
Links
- WLLOFQROROXOMO-GOSISDBHSA-N 4-[[4-[[4-[(3r)-oxolan-3-yl]oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-yl]methyl]oxan-4-ol Chemical compound C1CC(COC=2C3=C(O[C@H]4COCC4)C=CC=C3ON=2)CCN1CC1(O)CCOCC1 WLLOFQROROXOMO-GOSISDBHSA-N 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30492110P | 2010-02-16 | 2010-02-16 | |
| PCT/IB2011/050548 WO2011101774A1 (en) | 2010-02-16 | 2011-02-09 | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN06631A true IN2012DN06631A (instruction) | 2015-10-23 |
Family
ID=43904611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN6631DEN2012 IN2012DN06631A (instruction) | 2010-02-16 | 2011-02-09 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120041026A1 (instruction) |
| EP (1) | EP2536713A1 (instruction) |
| JP (1) | JP2013519722A (instruction) |
| KR (1) | KR20120123089A (instruction) |
| CN (1) | CN102762554A (instruction) |
| AR (1) | AR080172A1 (instruction) |
| AU (1) | AU2011216950A1 (instruction) |
| CA (1) | CA2788656A1 (instruction) |
| IN (1) | IN2012DN06631A (instruction) |
| MX (1) | MX2012008721A (instruction) |
| SG (1) | SG183111A1 (instruction) |
| TW (1) | TW201141856A (instruction) |
| UY (1) | UY33225A (instruction) |
| WO (1) | WO2011101774A1 (instruction) |
| ZA (1) | ZA201206469B (instruction) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| US10583138B2 (en) | 2012-07-12 | 2020-03-10 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| CA2836372C (en) * | 2011-05-18 | 2020-09-22 | Raqualia Pharma Inc. | Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2h-pyran-4-carboxylic acid |
| WO2014080633A1 (en) * | 2012-11-21 | 2014-05-30 | Raqualia Pharma Inc. | Polymorph forms |
| EA029365B1 (ru) | 2013-03-20 | 2018-03-30 | Сувен Лайф Сайенсиз Лимитед | 5-амино-хинолин-8-карбоксамидные производные в качестве агонистов 5-htрецептора |
| CA2932428C (en) | 2013-12-16 | 2017-10-24 | Suven Life Sciences Limited | Indazole compounds as 5-ht4 receptor agonists |
| TWI672300B (zh) * | 2014-05-20 | 2019-09-21 | 日商拉夸里亞創藥股份有限公司 | 苯并異唑衍生物鹽類 |
| HRP20191179T1 (hr) | 2015-02-13 | 2019-10-04 | Suven Life Sciences Limited | Spojevi amida kao agonisti 5-ht4 receptora |
| CN117796401A (zh) * | 2023-12-25 | 2024-04-02 | 江苏万隆化学有限公司 | 一种含2-羟基-6-氟苯甲酸甲酯中间体抗菌剂的制备工艺 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2104297C (en) | 1991-02-27 | 2003-05-27 | Boyd Lynn Harrison | 4-sulfanimide-quinoline nmda antagonists |
| US5750542A (en) * | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| AU690529B2 (en) * | 1992-11-23 | 1998-04-30 | Hoechst Marion Roussel, Inc. | Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds |
| IL117149A0 (en) | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| WO1997012870A1 (en) | 1995-09-29 | 1997-04-10 | Glaxo Wellcome S.P.A. | Tetrahydroquinolines as nmda antagonists |
| IL126003A0 (en) | 1996-04-10 | 1999-04-11 | Hoechst Marion Roussel Inc | Spiro [cyclopent [b] indole-piperidines] and n-[phenyl-hydrazon intermediates for their preparation both being acetyl cholinesterase and mao inhibitors |
| ATE207483T1 (de) | 1996-04-12 | 2001-11-15 | Aventis Pharma Inc | Isatinderivate als acetylcholinesterase- inhibitoren und analgetika |
| ES2179353T3 (es) | 1996-07-01 | 2003-01-16 | Schering Corp | Antagonistas muscarinicos. |
| JP3390179B2 (ja) | 1996-08-15 | 2003-03-24 | シェーリング コーポレイション | エーテルムスカリン様アンタゴニスト |
| KR20000048715A (ko) | 1996-09-30 | 2000-07-25 | 게리 디. 스트리트, 스티븐 엘. 네스비트 | Ｎｍｄａ (ｎ-메틸-ｄ-아스파르테이트) 길항제 |
| EP1891954A3 (en) | 1998-09-30 | 2009-01-14 | Takeda Pharmaceutical Company Limited | Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
| ATE380172T1 (de) | 2001-01-26 | 2007-12-15 | Btg Int Ltd | Benzylaminanalogen |
| CA2440284A1 (en) | 2001-03-08 | 2002-09-19 | Emory University | Ph-dependent nmda receptor antagonists |
| JP2005511478A (ja) | 2001-04-03 | 2005-04-28 | メルク エンド カムパニー インコーポレーテッド | Ｎ−置換非アリール複素環アミジル系ｎｍｄａ／ｎｒ２ｂ拮抗薬 |
| SI1409477T1 (sl) | 2001-07-24 | 2009-02-28 | Richter Gedeon Nyrt | Derivati piperidina kot antagonisti nmda-receptorjev |
| HRP20080490T3 (en) | 2003-06-04 | 2008-11-30 | Merck & Co. Inc. | 3-fluoro-piperidines as nmda/nr2b antagonists |
| GB0316094D0 (en) | 2003-07-09 | 2003-08-13 | Neuropharma Sa | Acetylcholinesterase dual inhibitors |
| SG10201400339VA (en) * | 2004-03-03 | 2014-05-29 | Revance Therapeutics Inc | Compositions And Methods For Topical Application And Transdermal Delivery Of Botulinum Toxins |
| HU227119B1 (en) | 2004-07-29 | 2010-07-28 | Richter Gedeon Nyrt | Indole and benzimidazole carboxylic acid amide derivatives and pharmaceutical compositions containing them |
| HU227000B1 (en) | 2004-07-29 | 2010-04-28 | Richter Gedeon Nyrt | Nmda receptor antagonist benzoyl urea derivatives, and pharmaceutical compositions containing them |
| HU226977B1 (en) | 2004-07-29 | 2010-04-28 | Richter Gedeon Nyrt | Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them |
| HUP0401523A3 (en) | 2004-07-29 | 2007-05-02 | Richter Gedeon Vegyeszet | Indole-2-carboxamide derivatives, pharmaceutical compositions containing them and process for producing them |
| HUP0401522A2 (en) | 2004-07-29 | 2006-04-28 | Richter Gedeon Vegyeszet | New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation |
| TW200621677A (en) | 2004-09-21 | 2006-07-01 | Astellas Pharma Inc | Cyclic amine derivative or salt thereof |
| MX2007004458A (es) | 2004-10-15 | 2007-08-08 | Univ Rio De Janeiro | Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes. |
| WO2006090224A1 (en) | 2005-02-25 | 2006-08-31 | Pfizer Japan Inc. | Benzisoxazole derivatives |
| US20090124600A1 (en) | 2005-04-19 | 2009-05-14 | Layton Mark E | N-Alkyl-Azacycloalkyl NMDA/NR2B Antagonists |
| US20090258824A1 (en) | 2005-07-29 | 2009-10-15 | Ashe Karen H | Amyloid beta receptor and uses thereof |
| CN101437510B (zh) | 2006-03-20 | 2012-12-05 | 科学与工业研究会 | 用作乙酰胆碱酯酶抑制剂的药物组合物 |
| ES2288406B1 (es) | 2006-04-20 | 2008-12-16 | Universidad De Barcelona | Compuestos inhibidores de acetilcolinesterasa para el tratamiento de la enfermedad de alzheimer. |
| WO2008074816A1 (en) | 2006-12-20 | 2008-06-26 | Solvay Pharmaceuticals B.V. | Compounds with a combination of cannabinoid-cb1 antagonism and acetylcholinesterase inhibition |
| US7605265B2 (en) | 2007-01-22 | 2009-10-20 | Biotechnology Research Corporation Ltd. | Heterodimers and methods of using them |
| DK2345653T3 (da) | 2007-05-01 | 2013-04-08 | Concert Pharmaceuticals Inc | Morphinanforbindelser |
| GB2462235B8 (en) | 2007-05-11 | 2013-03-27 | Biotechnology Res Corp Ltd | Receptor modulators exhibiting neuroprotective andmemory enhancing activities |
| AU2008272964A1 (en) | 2007-06-29 | 2009-01-08 | Emory University | NMDA receptor antagonists for neuroprotection |
| CA2699412A1 (en) | 2007-09-12 | 2009-03-19 | Virginia Tech Intellectual Properties, Inc. | Insecticidal carbamates exhibiting species-selective inhibition of acetylcholinesterase (ache) |
| WO2009092324A1 (en) | 2008-01-16 | 2009-07-30 | Hong Kong University Of Science And Technology | Oxazolidine derivatives as nmda antagonists |
| EA014100B1 (ru) | 2008-02-21 | 2010-08-30 | Общество С Ограниченной Ответственностью "Валексфарм" | Производные 2,4-диаминопиридина, фармацевтическая композиция, лекарственное средство на их основе для лечения или предупреждения заболеваний и нарушений, вызванных гиперактивацией nmda-рецепторов и/или в качестве стимуляторов когнитивных функций и способ лечения |
| CN101440061B (zh) | 2008-04-08 | 2010-12-08 | 温州医学院 | 一类具有抑制乙酰胆碱酯酶活性的芳基吡啶酮类衍生物 |
| WO2009129181A1 (en) | 2008-04-14 | 2009-10-22 | Concert Pharmaceuticals Inc. | Propanediol-dicarbamate derivatives |
| BRPI0912362A2 (pt) | 2008-05-09 | 2015-10-06 | Univ Emory | antagonista do receptor nmda para o tratamento de transtornos neuropsiquiátricos |
-
2011
- 2011-02-09 IN IN6631DEN2012 patent/IN2012DN06631A/en unknown
- 2011-02-09 SG SG2012053906A patent/SG183111A1/en unknown
- 2011-02-09 MX MX2012008721A patent/MX2012008721A/es not_active Application Discontinuation
- 2011-02-09 EP EP11710564A patent/EP2536713A1/en not_active Withdrawn
- 2011-02-09 CN CN2011800099647A patent/CN102762554A/zh active Pending
- 2011-02-09 CA CA2788656A patent/CA2788656A1/en not_active Abandoned
- 2011-02-09 AU AU2011216950A patent/AU2011216950A1/en not_active Abandoned
- 2011-02-09 JP JP2012553423A patent/JP2013519722A/ja not_active Withdrawn
- 2011-02-09 WO PCT/IB2011/050548 patent/WO2011101774A1/en active Application Filing
- 2011-02-09 KR KR1020127021310A patent/KR20120123089A/ko not_active Ceased
- 2011-02-14 UY UY0001033225A patent/UY33225A/es not_active Application Discontinuation
- 2011-02-14 AR ARP110100443A patent/AR080172A1/es not_active Application Discontinuation
- 2011-02-15 TW TW100104942A patent/TW201141856A/zh unknown
- 2011-02-16 US US13/028,368 patent/US20120041026A1/en not_active Abandoned
-
2012
- 2012-08-28 ZA ZA2012/06469A patent/ZA201206469B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20120041026A1 (en) | 2012-02-16 |
| AU2011216950A1 (en) | 2012-08-23 |
| SG183111A1 (en) | 2012-09-27 |
| JP2013519722A (ja) | 2013-05-30 |
| UY33225A (es) | 2011-09-30 |
| WO2011101774A1 (en) | 2011-08-25 |
| EP2536713A1 (en) | 2012-12-26 |
| KR20120123089A (ko) | 2012-11-07 |
| CN102762554A (zh) | 2012-10-31 |
| ZA201206469B (en) | 2013-05-29 |
| MX2012008721A (es) | 2012-08-17 |
| AR080172A1 (es) | 2012-03-21 |
| TW201141856A (en) | 2011-12-01 |
| CA2788656A1 (en) | 2011-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN06631A (instruction) | ||
| MX2009009428A (es) | Analogos de ciclopamina heterociclicos y metodos de uso de los mismos. | |
| PH12015501470A1 (en) | Compositions and methods for the control of nematodes and soil borne diseases | |
| MX2009009429A (es) | Analogos de ciclopamina lactama y metodos de uso de los mismos. | |
| AU2011367301A8 (en) | Apparatus and method for controlling brightness in potable terminal | |
| BR112012031620A2 (pt) | atm acessível para deficiente físico | |
| TW200720693A (en) | A comfortable ophthalmic device and methods of its production | |
| EP4335501A3 (en) | Use of estriol in low doses | |
| SI3392340T1 (sl) | Mikroorganizmi za proizvodnjo 1,4-BUTANDIOLA in pripadajoči postopki | |
| TN2009000185A1 (en) | Progesterone receptor antagonists | |
| EP3825403A3 (en) | Methods and compositions for modulating apolipoprotein(a) expression | |
| MX2014009657A (es) | Pilar dental para el soporte de protesis dentales y metodo de fabricacion del mismo. | |
| PH12014500541A1 (en) | Various control elements in a hybrid game | |
| NZ603625A (en) | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate | |
| AU2011305525A8 (en) | Modulators of the GPR119 receptor and the treatment of disorders related thereto | |
| TN2011000653A1 (en) | Pharmaceutical compositions and solid forms | |
| MY156946A (en) | Composition for decreasing hardness of water | |
| EP4494704A3 (en) | Use of cyclic amide derivatives to treat sleep disorders | |
| AU335070S (en) | Integrated winchhead | |
| PH12014500538A1 (en) | Methods and compositions for treating leukemia | |
| PL401820A1 (pl) | Uklad i sposób dezynfekcji i dezodoryzacji systemów gromadzenia odpadów wykorzystujace ozon | |
| IN2014CN00834A (instruction) | ||
| IN2014CN00817A (instruction) | ||
| WO2009120381A3 (en) | Faucet system and advertising method | |
| UA103263C2 (ru) | Способ увеличения полового члена и электромеханический экстендер для его реализации |